DLI Gentetic Research and Development Bioinformatics Training India | Bioinformatics Projects Hyderabad| Biotechnology Drug Designing Immunoinformatics Chemioinformatics and Rational Drug designing Computer Aided Drug Designing Protein Modeling, Drug Designing & Immunoinformatics Itanagar, Dispur, Patna, Chandigarh, Raipur, Silvassa, Daman, Delhi, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Nagpur, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Pondicherry, Chandigarh, Jaipur, Chennai , Agartala, Lucknow, Dehradun, Kolkata

DNA PRENATAL TESTING

Every parent hopes to have a healthy baby, but it can’t be.
How can Doctors know if the baby has a serious or untreatable health problem?

Tradational way is using a ultrasound machine, Which can only evaluate risk of a condition and cannot determine it 100%. If children born with severe disabilities, their lifelong care is very expensive.

DLI’s prenatal testing uses genetic testing to find the disorders which cant be detected by ultrasound. Over results gives parents a option to think before they make a decession. For example, Downs Syndrome is associated with cardiac defects that may need intervention immediately upon birth.

DNA LABS INDIA (DLI) Prenatal testing is testing for diseases or conditions in a fetus or embryo before it is born. The aim is to detect birth defects such as Down syndrome, genetic diseases and other conditions. Common testing procedures practeced is ultrasound. In some cases, the tests are administered to determine if the fetus will be aborted, though physicians and patients also find it useful to diagnose high-risk pregnancies early so that delivery can be scheduled in a tertiary care hospital where the baby can receive appropriate care. DLI has sucessfully done prenatal testing for hereditary diseases and genetic abnormalities. Prenatal testing requires the use of amniocentesis or chorionic villus sampling (CVS) to collect samples from embryo.
Down syndrome is one of the most common and well-known chromosome abnormalities, being a severe congenital pathology with mental retardation, immunity disorders and heart activity disorders, etc. It occurs because of the presence of an extra 21st

Prenatal testing is testing for diseases or conditions in a fetus or embryo before it is born. It gives parents a option to think before they make a decession. For children born with severe disabilities, their lifelong care is very expensive. Dear Doctors/Users of Medical Laboratory services,

We are pleased to offer our screening and diagnostic services as follow:

Test

Description

Specimen

Turnaround Time

First Trimester Screening (FTS)

FTS is a non-invasive screening test carried out on maternal serum obtained in first trimester pregnancy (between 11w0d and 13w6d gestation), to provide a service involves a risk calculation derived from combination of two biochemical placental markers; free Beta hCG and PAPP-A combined with the ultrasound marker Nuchal Translucency (11w0d-13w6d gestation) for the screening of the three most common fetal chromosomal abnormalities, namely, Trisomy 21(Down’s Syndrome), Trisomy 18 (Edwards’ Syndrome), and Trisomy 13 (Patau’s Syndrome).
Detection rate >90%1.
PerkinElmer’s DelfiaXpress instrument and first trimester assays are approved by Fetal Medicine Foundation (FMF), UK.

5ml Maternal Blood
(Plain Tube)

Report will be faxed within
7 Working Days

Second Trimester Screening (STS)/
Beta Triple
Test

Screening test carried out on maternal serum obtained in second trimester pregnancy (between 15w0d-20w6d). Includes a risk calculation derived from combination three biochemical markers:-
• Alpha-fetoprotein (AFP)
• Free Beta hCG
• Unconjugated Estriol (uE3)
PerkinElmer’s 2nd trimester screening markers have shown the best performance in the
UK EQAS quality control program since December 2002

5ml Maternal Blood
(Plain Tube)

Report will be faxed within
7 Working Days

Chromosomes- Check (Rapid
Aneuploidy
Detection)

Diagnostic test carried out on amniotic fluid cells, chorionic villus or foetal blood obtained in pregnancy. This rapid diagnostic tests for most common autosomal aneuploidies:-
• Trisomy 21 (Down’s Syndrome)
• Trisomy 18 (Edward’s Syndrome)
• Trisomy 13 (Patau’s Syndrome)
• Sex chromosomal aneuploidies (Klinefelter –XXY, XXX and XYY). (Detection rate:- 99.9%2)
Please included maternal blood if specimen is contaminated with blood.

5ml
Amniotic Fluid/
30mg CVS (Sterile Container)

Report will be faxed within
7 Working Days

Karyotype
Analysis

A snapshot of all chromosomes to identify a wide range of chromosomal abnormalities, including alterations in copy number (aneuploidy) as well as chromosomal rearrangements, such as translocations, deletion and inversions.

15ml
Amniotic Fluid/
30mg CVS (Please call hotline for further details)

Report will be faxed within
3 Weeks

HPV DNA Genotype

This test screens for :-
• 15 “high risk” HPV genotypes including 16, 18, 31, 33, 35, 39,
45,51, 52, 53, 56, 58, 59, 66, 68.
• 5 “low risk” HPV type including 6, 11, 41, 42, 44 which are responsible for ~90% of all cases of genital warts.

Cervical Swab (Transportation Medium)

Report will be faxed within
7 Working Days

LBC

Liquid Based Cytology (LBC) is the new cervical cell collection technique developed from the conventional method, the pap smear. LBC improves sample collection as it has the technology to clean the specimens thus enabling clean observation of cells.

Cervical Swab (Transportation Medium)

Report will be faxed within
10 Working Days

DNA Identification/Paternity Test

DNA profiling with STR markers used internationally.

* Please use paternity test request form DNA lab. Call to request. This test is not designed for legal proceedings.

5ml
EDTA Blood/
2-3ml
Amniotic Fluid

Report will be faxed within
5 Working Days

LABORATORY EQUIPMENT IS CERTIFIED BY